Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies

N-Methyl-D-aspartate receptors (NMDARs) have two opposing roles in the brain. On the one hand, NMDARs control critical events in the formation and development of synaptic organization and synaptic plasticity. On the other hand, the overactivation of NMDARs can promote neuronal death in neuropathological conditions. Ca2+ influx acts as a primary modulator after NMDAR channel activation. An imbalance in Ca2+ homeostasis is associated with several neurological diseases including schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. These chronic conditions have a lengthy progression depending on internal and external factors. External factors such as acute episodes of brain damage are associated with an earlier onset of several of these chronic mental conditions. Here, we will review some of the current evidence of how traumatic brain injury can hasten the onset of several neurological conditions, focusing on the role of NMDAR distribution and the functional consequences in calcium homeostasis associated with synaptic dysfunction and neuronal death present in this group of chronic diseases.

[1]  A. Schrag,et al.  Mild Cognitive Impairment in Parkinson’s Disease—What Is It? , 2018, Current Neurology and Neuroscience Reports.

[2]  M. Nance.  Genetics of Huntington disease. , 2017, Handbook of clinical neurology.

[3]  A. Vita,et al.  Schizophrenia , 2016, The Lancet.

[4]  M. Berger,et al.  Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis. , 2016, Journal of neurosurgery.

[5]  F. Clausen.  Animal Models of Traumatic Brain Injury , 2016 .

[6]  Marco Fuenzalida,et al.  Enhanced astroglial Ca2+ signaling increases excitatory synaptic strength in the epileptic brain , 2015, Glia.

[7]  J. Pierce,et al.  Traumatic Brain Injury and Mitochondrial Dysfunction , 2015, The American journal of the medical sciences.

[8]  V. Feigin,et al.  Prevalence, natural course and predictors of depression 1 year following traumatic brain injury from a population-based study in New Zealand , 2015, Brain injury.

[9]  J. Viña,et al.  Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease. , 2015, Free radical biology & medicine.

[10]  C. Tanner,et al.  Traumatic brain injury in later life increases risk for Parkinson disease , 2015, Annals of neurology.

[11]  M. Gearing,et al.  Head injury does not alter disease progression or neuropathologic outcomes in ALS , 2015, Neurology.

[12]  Anil Kumar,et al.  A review on Alzheimer’s disease pathophysiology and its management: an update , 2015, Pharmacological reports : PR.

[13]  T. Yen,et al.  Accumulation of amyloid in cognitive impairment after mild traumatic brain injury , 2015, Journal of the Neurological Sciences.

[14]  M. Feany,et al.  Connecting the dots between tau dysfunction and neurodegeneration. , 2015, Trends in cell biology.

[15]  B. Jordan.  Chronic Traumatic Encephalopathy and Other Long-term Sequelae , 2014, Continuum.

[16]  A. Ansari,et al.  Role of sertraline in posttraumatic brain injury depression and quality-of-life in TBI , 2014, Asian journal of neurosurgery.

[17]  Y. T. Wang,et al.  The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse , 2014, Front. Cell. Neurosci..

[18]  L. Raymond,et al.  Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders , 2014, Neuron.

[19]  I. Ferreira,et al.  Dysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors , 2014, Neuropharmacology.

[20]  P. Bertolucci,et al.  Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease , 2014, Journal of the Neurological Sciences.

[21]  Richard J. Kryscio,et al.  Self-Reported Head Injury and Risk of Late-Life Impairment and AD Pathology in an AD Center Cohort , 2013, Dementia and Geriatric Cognitive Disorders.

[22]  Yadin Dudai,et al.  Memorable Trends , 2013, Neuron.

[23]  N. Danbolt,et al.  GABA and Glutamate Transporters in Brain , 2013, Front. Endocrinol..

[24]  M. Etminan,et al.  Head injury and risk of Parkinson disease: A systematic review and meta‐analysis , 2013, Movement disorders : official journal of the Movement Disorder Society.

[25]  R. Morimoto,et al.  Huntington's disease: underlying molecular mechanisms and emerging concepts. , 2013, Trends in biochemical sciences.

[26]  S. Chapman,et al.  Psychiatric disorders in children and adolescents in the first six months after mild traumatic brain injury. , 2013, The Journal of neuropsychiatry and clinical neurosciences.

[27]  C. Ferrario,et al.  Stretch injury selectively enhances extrasynaptic, GluN2B-containing NMDA receptor function in cortical neurons. , 2013, Journal of neurophysiology.

[28]  Yuan Liu,et al.  Inhibiting PTEN Protects Hippocampal Neurons against Stretch Injury by Decreasing Membrane Translocation of AMPA Receptor GluR2 Subunit , 2013, PloS one.

[29]  Erin B D Clabough.  Huntington’s Disease: The Past, Present, and Future Search for Disease Modifiers , 2013, The Yale journal of biology and medicine.

[30]  R. Nitsch,et al.  NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss , 2013, Cell Death and Disease.

[31]  David K. Menon,et al.  Changing patterns in the epidemiology of traumatic brain injury , 2013, Nature Reviews Neurology.

[32]  A. Adejare,et al.  NMDA Receptor Antagonists for Treatment of Depression , 2013, Pharmaceuticals.

[33]  C. Spilker,et al.  Encoding and Transducing the Synaptic or Extrasynaptic Origin of NMDA Receptor Signals to the Nucleus , 2013, Cell.

[34]  Michael Chopp,et al.  Animal models of traumatic brain injury , 2013, Nature Reviews Neuroscience.

[35]  J. Ballenger.  Targeting the Glutamatergic System to Treat Major Depressive Disorder: Rationale and Progress to Date , 2013 .

[36]  Reisa A. Sperling,et al.  Subjective cognitive complaints and amyloid burden in cognitively normal older individuals , 2012, Neuropsychologia.

[37]  D. Jane,et al.  Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators , 2012, Neurochemistry International.

[38]  L. Raymond,et al.  Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model. , 2012, Human molecular genetics.

[39]  S. Oliet,et al.  Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists , 2012, Cell.

[40]  A. Al-Chalabi,et al.  The genetics and neuropathology of amyotrophic lateral sclerosis , 2012, Acta Neuropathologica.

[41]  H. Taylor,et al.  Age at injury and long-term behavior problems after traumatic brain injury in young children. , 2012, Rehabilitation psychology.

[42]  D. Fujii,et al.  Psychotic disorder due to traumatic brain injury: analysis of case studies in the literature. , 2012, The Journal of neuropsychiatry and clinical neurosciences.

[43]  R. Owen.  Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole. , 2012, Drugs of today.

[44]  K. Manaye,et al.  Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar–Kyoto rats , 2012, Neuroscience.

[45]  P. Kind,et al.  The Subtype of GluN2 C-terminal Domain Determines the Response to Excitotoxic Insults , 2012, Neuron.

[46]  Akira Wada,et al.  Increased ratio of calcineurin immunoreactive neurons in the caudate nucleus of patients with schizophrenia , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[47]  Douglas H. Smith,et al.  Widespread Tau and Amyloid‐Beta Pathology Many Years After a Single Traumatic Brain Injury in Humans , 2012, Brain pathology.

[48]  Y. Auberson,et al.  Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. , 2012, Cell Calcium.

[49]  E. Engleman,et al.  Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) Inhibition Induces Neurotoxicity via Dysregulation of Glutamate/Calcium Signaling and Hyperexcitability* , 2012, The Journal of Biological Chemistry.

[50]  C. Zarate,et al.  Targeting the Glutamatergic System to Treat Major Depressive Disorder , 2012, Drugs.

[51]  J. Jankovic,et al.  Head injury, alpha‐synuclein Rep1, and Parkinson's disease , 2012, Annals of neurology.

[52]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[53]  K. Reymann,et al.  Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptors , 2011, Neurobiology of Aging.

[54]  G A Perkins,et al.  A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics , 2011, Cell Death and Disease.

[55]  Z. Xu,et al.  Moderate Traumatic Brain Injury Causes Acute Dendritic and Synaptic Degeneration in the Hippocampal Dentate Gyrus , 2011, PloS one.

[56]  J. Lacaille,et al.  Astrocytes Are Endogenous Regulators of Basal Transmission at Central Synapses , 2011, Cell.

[57]  J. Little,et al.  Roles of reactive oxygen and nitrogen species in pain. , 2011, Free radical biology & medicine.

[58]  N. Nakamichi,et al.  A possible pivotal role of mitochondrial free calcium in neurotoxicity mediated by N-methyl-d-aspartate receptors in cultured rat hippocampal neurons , 2011, Neurochemistry International.

[59]  A. Acevedo-Arozena,et al.  SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments , 2011, Mammalian Genome.

[60]  Manuel Roncagliolo,et al.  Glutamate released spontaneously from astrocytes sets the threshold for synaptic plasticity , 2011, The European journal of neuroscience.

[61]  V. Anderson,et al.  Long-term outcome from childhood traumatic brain injury: intellectual ability, personality, and quality of life. , 2011, Neuropsychology.

[62]  M. Behari,et al.  Mitochondrial Perturbance and Execution of Apoptosis in Platelet Mitochondria of Patients With Amyotrophic Lateral Sclerosis , 2011, The International journal of neuroscience.

[63]  L. Martin.  An Approach to Experimental Synaptic Pathology Using Green Fluorescent Protein-Transgenic Mice and Gene Knockout Mice to Show Mitochondrial Permeability Transition Pore-Driven Excitotoxicity in Interneurons and Motoneurons , 2011, Toxicologic pathology.

[64]  Y. T. Wang,et al.  Fashioning drugs for stroke , 2010, Nature Medicine.

[65]  W. Lu,et al.  Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95 , 2010, Nature Medicine.

[66]  H. Bading,et al.  Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders , 2010, Nature Reviews Neuroscience.

[67]  R. Dingledine,et al.  Glutamate Receptor Ion Channels: Structure, Regulation, and Function , 2010, Pharmacological Reviews.

[68]  B. Masel,et al.  Traumatic brain injury: a disease process, not an event. , 2010, Journal of neurotrauma.

[69]  H. Bading,et al.  Synaptic Activity and Nuclear Calcium Signaling Protect Hippocampal Neurons from Death Signal-associated Nuclear Translocation of FoxO3a Induced by Extrasynaptic N-Methyl-d-aspartate Receptors* , 2010, The Journal of Biological Chemistry.

[70]  Paolo Calabresi,et al.  Synaptic dysfunction in Parkinson's disease. , 2012, Advances in experimental medicine and biology.

[71]  M. Wald,et al.  Traumatic brain injury in the United States; emergency department visits, hospitalizations, and deaths, 2002-2006 , 2010 .

[72]  L. Raymond,et al.  Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice , 2010, Neuron.

[73]  M. M. Soundarapandian,et al.  DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke , 2010, Cell.

[74]  香村 彰宏.  A novel calpain inhibitor, ((1S)-1((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice , 2010 .

[75]  Xiaomin Wang,et al.  Amyloid-β induces caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors. , 2010, Journal of Alzheimer's disease : JAD.

[76]  J. Simard,et al.  Novel model of frontal impact closed head injury in the rat. , 2009, Journal of neurotrauma.

[77]  P. Andersen,et al.  Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[78]  C. Heckman,et al.  Motoneuron excitability: The importance of neuromodulatory inputs , 2009, Clinical Neurophysiology.

[79]  P Jeffrey Conn,et al.  Glutamate receptors as therapeutic targets for Parkinson's disease. , 2009, CNS & neurological disorders drug targets.

[80]  Susanne A Schneider,et al.  Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[81]  Michael R. Hayden,et al.  Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin , 2009, Nature Medicine.

[82]  T. Iglesias,et al.  Kidins220/ARMS downregulation by excitotoxic activation of NMDARs reveals its involvement in neuronal survival and death pathways , 2009, Journal of Cell Science.

[83]  C. Matute,et al.  Endoplasmic reticulum Ca(2+) release through ryanodine and IP(3) receptors contributes to neuronal excitotoxicity. , 2009, Cell calcium.

[84]  C. Fairbanks,et al.  Disruption of nNOS‐PSD95 protein–protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents , 2009, British journal of pharmacology.

[85]  E. Park,et al.  PICK1-mediated GluR2 endocytosis contributes to cellular injury after neuronal trauma , 2009, Cell Death and Differentiation.

[86]  J. Bibb,et al.  Extrasynaptic NMDA Receptors Couple Preferentially to Excitotoxicity via Calpain-Mediated Cleavage of STEP , 2009, The Journal of Neuroscience.

[87]  J. Coyle,et al.  Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophrenia , 2009, Schizophrenia Research.

[88]  Alexander Münchau,et al.  Abnormal Motor Cortex Excitability in Preclinical and Very Early Huntington's Disease , 2009, Biological Psychiatry.

[89]  E. Foran,et al.  Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. , 2009, Antioxidants & redox signaling.

[90]  J. Rafols,et al.  RETRACTED: Synapse loss regulated by matrix metalloproteinases in traumatic brain injury is associated with hypoxia inducible factor-1α expression , 2009, Brain Research.

[91]  B. Greenwald,et al.  A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury. , 2009, Archives of physical medicine and rehabilitation.

[92]  K. Davies,et al.  Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices , 2009, Neuroscience.

[93]  D. Choquet,et al.  Surface trafficking of N-methyl-d-aspartate receptors: Physiological and pathological perspectives , 2009, Neuroscience.

[94]  Benjamin D. Philpot,et al.  Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity , 2008, Neuropharmacology.

[95]  A. Buisson,et al.  Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[96]  L. Raymond,et al.  Polyglutamine-Modulated Striatal Calpain Activity in YAC Transgenic Huntington Disease Mouse Model: Impact on NMDA Receptor Function and Toxicity , 2008, The Journal of Neuroscience.

[97]  H. Hara,et al.  A novel calpain inhibitor, ((1S)-1((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice , 2008, Neuroscience.

[98]  Z. Xiong,et al.  Differential Roles of NMDA Receptor Subtypes in Ischemic Neuronal Cell Death and Ischemic Tolerance , 2008, Stroke.

[99]  I. Bezprozvanny,et al.  Evaluation of Dimebon in cellular model of Huntington's disease , 2008, Molecular Neurodegeneration.

[100]  D. Meaney,et al.  Calcium-permeable AMPA receptors appear in cortical neurons after traumatic mechanical injury and contribute to neuronal fate. , 2008, Journal of neurotrauma.

[101]  P. Vosler,et al.  Calpain-Mediated Signaling Mechanisms in Neuronal Injury and Neurodegeneration , 2008, Molecular Neurobiology.

[102]  A. Biegon,et al.  Inhibition of NR2B phosphorylation restores alterations in NMDA receptor expression and improves functional recovery following traumatic brain injury in mice. , 2008, Journal of neurotrauma.

[103]  R. Bullock,et al.  Moderate and severe traumatic brain injury in adults , 2008, The Lancet Neurology.

[104]  C. Sumiyoshi,et al.  Calcineurin A gamma and B gene expressions in the whole blood in Japanese patients with schizophrenia , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[105]  L. Barbeito,et al.  Mitochondrial Dysfunction in SOD1G93A-Bearing Astrocytes Promotes Motor Neuron Degeneration: Prevention by Mitochondrial-Targeted Antioxidants , 2008, The Journal of Neuroscience.

[106]  P. Ghazal,et al.  Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses , 2008, Nature Neuroscience.

[107]  Vishnu Suppiramaniam,et al.  Amyloid beta peptides and glutamatergic synaptic dysregulation , 2008, Experimental Neurology.

[108]  C. Garner,et al.  Caldendrin–Jacob: A Protein Liaison That Couples NMDA Receptor Signalling to the Nucleus , 2008, PLoS biology.

[109]  Jane S. Paulsen,et al.  Detection of Huntington’s disease decades before diagnosis: the Predict-HD study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[110]  D. Nicholls,et al.  Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity , 2007, Journal of neuroscience research.

[111]  S. Cuzzocrea,et al.  Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. , 2007, The Journal of clinical investigation.

[112]  Alexander Z. Harris,et al.  Extrasynaptic and synaptic NMDA receptors form stable and uniform pools in rat hippocampal slices , 2007, The Journal of physiology.

[113]  Honglei Chen,et al.  Head injury and amyotrophic lateral sclerosis. , 2007, American journal of epidemiology.

[114]  Roger M. Nitsch,et al.  Intracellular Aβ and cognitive deficits precede β-amyloid deposition in transgenic arcAβ mice , 2007, Neurobiology of Aging.

[115]  M. Guo,et al.  Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease , 2007, Current Opinion in Neurobiology.

[116]  D. Purpura,et al.  NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders , 2007, Nature Reviews Neuroscience.

[117]  M. Strong,et al.  Calcium mediated excitotoxicity in neurofilament aggregate-bearing neurons in vitro is NMDA receptor dependant , 2007, Journal of the Neurological Sciences.

[118]  D. Sulzer,et al.  Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease , 2007, Trends in Neurosciences.

[119]  K. Murphy,et al.  Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease , 2007, Brain Research Bulletin.

[120]  Ann Marie Craig,et al.  NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both In Vitro and In Vivo , 2007, The Journal of Neuroscience.

[121]  Hilmar Bading,et al.  Decoding NMDA Receptor Signaling: Identification of Genomic Programs Specifying Neuronal Survival and Death , 2007, Neuron.

[122]  Quan-guang Zhang,et al.  Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury , 2007, FEBS letters.

[123]  S. Baker.  PTEN Enters the Nuclear Age , 2007, Cell.

[124]  C. Beyer,et al.  Differentiating antidepressants of the future: efficacy and safety. , 2007, Pharmacology & therapeutics.

[125]  L. Liaudet,et al.  Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.

[126]  I. Black,et al.  Brain-derived neurotrophic factor rapidly increases NMDA receptor channel activity through Fyn-mediated phosphorylation , 2006, Brain Research.

[127]  D. Kupfer,et al.  Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report , 2006 .

[128]  M. di Luca,et al.  Calcium–calmodulin‐dependent protein kinase II phosphorylation modulates PSD‐95 binding to NMDA receptors , 2006, The European journal of neuroscience.

[129]  Hilaire J Thompson,et al.  Traumatic Brain Injury in Older Adults: Epidemiology, Outcomes, and Future Implications , 2006, Journal of the American Geriatrics Society.

[130]  E. Mazzon,et al.  A Role for Nitric Oxide-Mediated Peroxynitrite Formation in a Model of Endotoxin-Induced Shock , 2006, Journal of Pharmacology and Experimental Therapeutics.

[131]  Daniel Choquet,et al.  AMPA and NMDA glutamate receptor trafficking: multiple roads for reaching and leaving the synapse , 2006, Cell and Tissue Research.

[132]  Karin E. Borgmann-Winter,et al.  Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia , 2006, Nature Medicine.

[133]  David Oakes,et al.  Head injury and Parkinson's disease risk in twins , 2006, Annals of neurology.

[134]  Maurizio Fava,et al.  A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. , 2006, The American journal of psychiatry.

[135]  A. Kimchi,et al.  The death-associated protein kinases: structure, function, and beyond. , 2006, Annual review of biochemistry.

[136]  K. Nikolich,et al.  Regulation of NMDA receptor trafficking and function by striatal‐enriched tyrosine phosphatase (STEP) , 2006, The European journal of neuroscience.

[137]  G. Xiong,et al.  Mechanisms underlying the inability to induce area CA1 LTP in the mouse after traumatic brain injury , 2006, Hippocampus.

[138]  Jacki Y. Brown,et al.  Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease. , 2006, Human molecular genetics.

[139]  Y. Ben-Ari,et al.  Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal‐regulated kinases (ERK) activity in cultured rat hippocampal neurons , 2006, The Journal of physiology.

[140]  Y. Auberson,et al.  Traumatic mechanical injury to the hippocampus in vitro causes regional caspase-3 and calpain activation that is influenced by NMDA receptor subunit composition , 2006, Neurobiology of Disease.

[141]  P. Calabresi,et al.  A Critical Interaction between NR2B and MAGUK in l-DOPA Induced Dyskinesia , 2006, The Journal of Neuroscience.

[142]  Tommaso Fellin,et al.  Glutamate release from astrocytes as a non-synaptic mechanism for neuronal synchronization in the hippocampus , 2006, Journal of Physiology-Paris.

[143]  Judith A. Callan,et al.  Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. , 2006, The Journal of clinical psychiatry.

[144]  J. Langlois,et al.  Traumatic brain injury in the United States; emergency department visits, hospitalizations, and deaths , 2006 .

[145]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[146]  S. Polinder,et al.  Cost estimation of injury-related hospital admissions in 10 European countries. , 2005, The Journal of trauma.

[147]  R. Malinow,et al.  NMDA Receptor Subunit Composition Controls Synaptic Plasticity by Regulating Binding to CaMKII , 2005, Neuron.

[148]  S. Scheff,et al.  Synaptogenesis in the hippocampal CA1 field following traumatic brain injury. , 2005, Journal of neurotrauma.

[149]  María Angeles Peinado,et al.  The role of free radicals in cerebral hypoxia and ischemia. , 2005, Free radical biology & medicine.

[150]  M. Sheng,et al.  Differential Roles of NR2A- and NR2B-Containing NMDA Receptors in Ras-ERK Signaling and AMPA Receptor Trafficking , 2005, Neuron.

[151]  F. Schliess,et al.  Lipopolysaccharide‐induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat , 2005, Hepatology.

[152]  N. Hardingham,et al.  Nuclear Ca2+ and the cAMP Response Element-Binding Protein Family Mediate a Late Phase of Activity-Dependent Neuroprotection , 2005, The Journal of Neuroscience.

[153]  Sung-Wan Kim,et al.  Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury , 2005, Human psychopharmacology.

[154]  B. Morris,et al.  PCP: from pharmacology to modelling schizophrenia. , 2005, Current opinion in pharmacology.

[155]  N. Rothwell,et al.  Cleavage of the Plasma Membrane Na+/Ca2+ Exchanger in Excitotoxicity , 2005, Cell.

[156]  J. Coyle,et al.  NAAG Reduces NMDA Receptor Current in CA1 Hippocampal Pyramidal Neurons of Acute Slices and Dissociated Neurons , 2005, Neuropsychopharmacology.

[157]  D. Hovda,et al.  Injury-induced alterations in N-methyl-d-aspartate receptor subunit composition contribute to prolonged 45calcium accumulation following lateral fluid percussion , 2004, Neuroscience.

[158]  John Q. Trojanowski,et al.  Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury , 2004, Experimental Neurology.

[159]  T. Gillingwater,et al.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.

[160]  P. Dodd,et al.  Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer’s disease , 2004, Neurochemistry International.

[161]  M. Sheng,et al.  PDZ domain proteins of synapses , 2004, Nature Reviews Neuroscience.

[162]  A. Lau,et al.  Vulnerability of Central Neurons to Secondary Insults after In Vitro Mechanical Stretch , 2004, The Journal of Neuroscience.

[163]  E. Masini,et al.  Superoxide-mediated nitration of spinal manganese superoxide dismutase: a novel pathway in N-methyl-d-aspartate-mediated hyperalgesia , 2004, Pain.

[164]  O. Tasaki,et al.  CHANGES IN CSF S100B AND CYTOKINE CONCENTRATIONS IN EARLY-PHASE SEVERE TRAUMATIC BRAIN INJURY , 2004, Shock.

[165]  P. Calabresi,et al.  Abnormal Ca2+-Calmodulin-Dependent Protein Kinase II Function Mediates Synaptic and Motor Deficits in Experimental Parkinsonism , 2004, The Journal of Neuroscience.

[166]  John W Griffin,et al.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.

[167]  M. Hayden,et al.  Inhibition of Calpain Cleavage of Huntingtin Reduces Toxicity , 2004, Journal of Biological Chemistry.

[168]  M. Kennedy,et al.  Regulation of the Neuron-specific Ras GTPase-activating Protein, synGAP, by Ca2+/Calmodulin-dependent Protein Kinase II* , 2004, Journal of Biological Chemistry.

[169]  M. Fehlings,et al.  Dual Neuroprotective Signaling Mediated by Downregulating Two Distinct Phosphatase Activities of PTEN , 2004, The Journal of Neuroscience.

[170]  Rafael Radi,et al.  Nitric oxide, oxidants, and protein tyrosine nitration , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[171]  R. Huganir,et al.  MAPK cascade signalling and synaptic plasticity , 2004, Nature Reviews Neuroscience.

[172]  J. Povlishock,et al.  Long-term potentiation deficits and excitability changes following traumatic brain injury , 2004, Experimental Brain Research.

[173]  M. Tymianski,et al.  Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury , 2004, Cellular and Molecular Life Sciences CMLS.

[174]  J. Macdonald,et al.  Enhanced vulnerability to NMDA toxicity in sublethal traumatic neuronal injury in vitro. , 2003, Journal of neurotrauma.

[175]  J. Trojanowski,et al.  Age-dependent synuclein pathology following traumatic brain injury in mice , 2003, Experimental Neurology.

[176]  M. Tymianski,et al.  Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. , 2003, Cell calcium.

[177]  Susumu Tonegawa,et al.  Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[178]  Leonard Evans,et al.  Traffic-law enforcement and risk of death from motor-vehicle crashes: case-crossover study , 2003, The Lancet.

[179]  J. P. Schwartz,et al.  Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice , 2003, Neuroscience.

[180]  C. Szabó.  Multiple pathways of peroxynitrite cytotoxicity. , 2003, Toxicology letters.

[181]  C. Szabó,et al.  Inosine Protects Against the Development of Diabetes in Multiple-Low-Dose Streptozotocin and Nonobese Diabetic Mouse Models of Type 1 Diabetes , 2003, Molecular medicine.

[182]  M. Segal,et al.  Hydrogen Peroxide Modulation of Synaptic Plasticity , 2003, The Journal of Neuroscience.

[183]  Yitao Liu,et al.  Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions , 2002, Science.

[184]  Yu Tian Wang,et al.  Dual Regulation of NMDA Receptor Functions by Direct Protein-Protein Interactions with the Dopamine D1 Receptor , 2002, Cell.

[185]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[186]  P. Marin,et al.  Akt mediates the anti‐apoptotic effect of NMDA but not that induced by potassium depolarization in cultured cerebellar granule cells , 2002, The European journal of neuroscience.

[187]  Roberto Malinow,et al.  Subunit-Specific NMDA Receptor Trafficking to Synapses , 2002, Neuron.

[188]  W. Guo,et al.  Tyrosine Phosphorylation of the NR2B Subunit of the NMDA Receptor in the Spinal Cord during the Development and Maintenance of Inflammatory Hyperalgesia , 2002, The Journal of Neuroscience.

[189]  P. Lombroso,et al.  Striatal Enriched Phosphatase 61 Dephosphorylates Fyn at Phosphotyrosine 420* , 2002, The Journal of Biological Chemistry.

[190]  H. Bading,et al.  Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways , 2002, Nature Neuroscience.

[191]  Akira Sawa,et al.  Schizophrenia: Diverse Approaches to a Complex Disease , 2002, Science.

[192]  M. Vitek,et al.  Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[193]  D. Marion,et al.  Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. , 2002, Journal of neurotrauma.

[194]  Xiaoqing Yuan,et al.  N‐methyl‐D‐aspartate receptors: Transient loss of NR1/NR2A/NR2B subunits after traumatic brain injury in a rodent model , 2002, Journal of neuroscience research.

[195]  Z. Qin,et al.  Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[196]  M. Pericak-Vance,et al.  The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis , 2001, Nature Genetics.

[197]  J. Coyle,et al.  The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. , 2001, The American journal of psychiatry.

[198]  K. Roche,et al.  Molecular determinants of NMDA receptor internalization , 2001, Nature Neuroscience.

[199]  J. Kreutzer,et al.  The prevalence and symptom rates of depression after traumatic brain injury: a comprehensive examination , 2001, Brain injury.

[200]  H. Bading,et al.  A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication , 2001, Nature Neuroscience.

[201]  Mark Farrant,et al.  NMDA receptor subunits: diversity, development and disease , 2001, Current Opinion in Neurobiology.

[202]  Hilmar Bading,et al.  Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity , 2001, Nature Neuroscience.

[203]  M. di Luca,et al.  Hippocampal Synaptic Plasticity Involves Competition between Ca2+/Calmodulin-Dependent Protein Kinase II and Postsynaptic Density 95 for Binding to the NR2A Subunit of the NMDA Receptor , 2001, The Journal of Neuroscience.

[204]  T. Soderling,et al.  Cellular Signaling through Multifunctional Ca2+/Calmodulin-dependent Protein Kinase II* , 2001, The Journal of Biological Chemistry.

[205]  L. Chandler,et al.  N-Methyl d-Aspartate Receptor-mediated Bidirectional Control of Extracellular Signal-regulated Kinase Activity in Cortical Neuronal Cultures* , 2001, The Journal of Biological Chemistry.

[206]  D. Tracey,et al.  HYPERALGESIA DUE TO NERVE INJURY— ROLE OF PEROXYNITRITE , 2000 .

[207]  A. Davis,et al.  Mechanisms of traumatic brain injury: biomechanical, structural and cellular considerations. , 2000, Critical care nursing quarterly.

[208]  W. Willis,et al.  Enhanced Phosphorylation of NMDA Receptor 1 Subunits in Spinal Cord Dorsal Horn and Spinothalamic Tract Neurons after Intradermal Injection of Capsaicin in Rats , 2000, The Journal of Neuroscience.

[209]  M. Kaul,et al.  Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury , 2000, Neuroscience.

[210]  S. Innerarity.  Hypomagnesemia in acute and chronic illness. , 2000, Critical care nursing quarterly.

[211]  E. J. Green,et al.  Chronic failure in the maintenance of long-term potentiation following fluid percussion injury in the rat , 2000, Brain Research.

[212]  D. Tracey,et al.  Hyperalgesia due to nerve injury—role of peroxynitrite , 2000, Neuroscience.

[213]  D. Attwell,et al.  Glutamate release in severe brain ischaemia is mainly by reversed uptake , 2000, Nature.

[214]  W Singer,et al.  Genetic and epigenetic regulation of NMDA receptor expression in the rat visual cortex , 1999, The European journal of neuroscience.

[215]  M. Lynch,et al.  Age-related changes in oxidative mechanisms and LTP are reversed by dietary manipulation , 1999, Neurobiology of Aging.

[216]  Arthur Konnerth,et al.  Early postnatal switch in magnesium sensitivity of NMDA receptors in rat CA1 pyramidal cells , 1999, The Journal of physiology.

[217]  M. Bear,et al.  Bidirectional, experience-dependent regulation of N-methyl-D-aspartate receptor subunit composition in the rat visual cortex during postnatal development. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[218]  M. Moskowitz,et al.  Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.

[219]  M. Guérin,et al.  Neurodegenerative disorders: the role of peroxynitrite , 1999, Brain Research Reviews.

[220]  Jin-Moo Lee,et al.  The changing landscape of ischaemic brain injury mechanisms , 1999, Nature.

[221]  J. Macdonald,et al.  Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. , 1999, Science.

[222]  G. Westbrook,et al.  The Incorporation of NMDA Receptors with a Distinct Subunit Composition at Nascent Hippocampal Synapses In Vitro , 1999, The Journal of Neuroscience.

[223]  J. Trojanowski,et al.  Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging. , 1999, The Journal of comparative neurology.

[224]  B. Sokolov,et al.  Expression of NMDAR1, GluR1, GluR7, and KA1 Glutamate Receptor mRNAs Is Decreased in Frontal Cortex of “Neuroleptic‐Free” Schizophrenics: Evidence on Reversible Up‐Regulation by Typical Neuroleptics , 1998, Journal of neurochemistry.

[225]  A. Lang,et al.  Parkinson's disease. Second of two parts. , 1998, The New England journal of medicine.

[226]  A. Lang,et al.  Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.

[227]  T. Peng,et al.  Visualization of NMDA Receptor-Induced Mitochondrial Calcium Accumulation in Striatal Neurons , 1998, Experimental Neurology.

[228]  P. De Koninck,et al.  Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. , 1998, Science.

[229]  J. Kleinman,et al.  Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains , 1997, Synapse.

[230]  S. Scheff,et al.  Morris water maze deficits in rats following traumatic brain injury: lateral controlled cortical impact. , 1997, Journal of neurotrauma.

[231]  David R. Kaplan,et al.  Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.

[232]  A. Volterra,et al.  Peroxynitrite Inhibits Glutamate Transporter Subtypes (*) , 1996, The Journal of Biological Chemistry.

[233]  J. Olney,et al.  Excitotoxicity and the NMDA receptor - still lethal after eight years , 1995, Trends in Neurosciences.

[234]  R. White,et al.  Mitochondria and Na+/Ca2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[235]  Michael R. Green,et al.  Nuclear protein CBP is a coactivator for the transcription factor CREB , 1994, Nature.

[236]  L. Murray,et al.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[237]  S. Lipton,et al.  Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.

[238]  B. Sakmann,et al.  Developmental and regional expression in the rat brain and functional properties of four NMDA receptors , 1994, Neuron.

[239]  Masatoshi Hagiwara,et al.  Phosphorylated CREB binds specifically to the nuclear protein CBP , 1993, Nature.

[240]  Charles Tator,et al.  Secondary Ca2+ overload indicates early neuronal injury which precedes staining with viability indicators , 1993, Brain Research.

[241]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[242]  T. Rauen,et al.  Comparative analysis of sodium‐dependent l‐glutamate transport of synaptosomal and astroglial membrane vesicles from mouse cortex , 1992, FEBS letters.

[243]  P. Calabresi,et al.  Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum , 1992, Neuroscience Letters.

[244]  G. Skuza,et al.  The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test. , 1992, Polish journal of pharmacology and pharmacy.

[245]  G. Skuza,et al.  The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist , 1992, Neuropharmacology.

[246]  J. Rothstein,et al.  Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. , 1992, The New England journal of medicine.

[247]  R. Blasco,et al.  Selective Inhibition of Calcium Entry Induced by Benzylisoquinolines in Rat Smooth Muscle , 1992, The Journal of pharmacy and pharmacology.

[248]  Tom Starzl,et al.  THE LANCET , 1992, The Lancet.

[249]  M E Greenberg,et al.  Stimulation of protein tyrosine phosphorylation by NMDA receptor activation , 1991, Science.

[250]  M. Thomas,et al.  Evaluation of memory dysfunction following experimental brain injury using the Morris water maze. , 1991, Journal of neurotrauma.

[251]  J. Coyle,et al.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[252]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[253]  R. Vink,et al.  The role of excitatory amino acids and NMDA receptors in traumatic brain injury. , 1989, Science.

[254]  D. Choi,et al.  N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. , 1987, The Journal of pharmacology and experimental therapeutics.

[255]  S. Rothman.  Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[256]  A. Sobel,et al.  The Journal of Biological Chemistry. , 2009, Nutrition reviews.

[257]  J. Olney.  Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate , 1969, Science.

[258]  D. Lucas,et al.  The toxic effect of sodium L-glutamate on the inner layers of the retina. , 1957, A.M.A. archives of ophthalmology.